DK2909334T3 - Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom - Google Patents

Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom Download PDF

Info

Publication number
DK2909334T3
DK2909334T3 DK13779214.9T DK13779214T DK2909334T3 DK 2909334 T3 DK2909334 T3 DK 2909334T3 DK 13779214 T DK13779214 T DK 13779214T DK 2909334 T3 DK2909334 T3 DK 2909334T3
Authority
DK
Denmark
Prior art keywords
crohn
liver
disease
inflammatory disorders
disorders related
Prior art date
Application number
DK13779214.9T
Other languages
English (en)
Inventor
Pierre Rimbaud
Stanislav Ehrlich
Matthieu Pichaud
Original Assignee
Enterome
Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterome, Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement filed Critical Enterome
Application granted granted Critical
Publication of DK2909334T3 publication Critical patent/DK2909334T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK13779214.9T 2012-10-17 2013-10-17 Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom DK2909334T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306286 2012-10-17
PCT/EP2013/071793 WO2014060555A1 (en) 2012-10-17 2013-10-17 Gene signatures of inflammatory disorders that relate to the liver

Publications (1)

Publication Number Publication Date
DK2909334T3 true DK2909334T3 (da) 2020-09-28

Family

ID=47148686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13779214.9T DK2909334T3 (da) 2012-10-17 2013-10-17 Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom

Country Status (14)

Country Link
US (2) US10036074B2 (da)
EP (1) EP2909334B1 (da)
JP (2) JP6752016B2 (da)
CN (1) CN104769132B (da)
AU (2) AU2013333882B2 (da)
BR (1) BR112015008621A2 (da)
CA (1) CA2886748A1 (da)
DK (1) DK2909334T3 (da)
ES (1) ES2821383T3 (da)
IL (1) IL238025B (da)
IN (1) IN2015DN03796A (da)
MX (1) MX2015004844A (da)
NZ (1) NZ707035A (da)
WO (1) WO2014060555A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10039777B2 (en) 2012-03-20 2018-08-07 Neuro-Lm Sas Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
CN115887508A (zh) 2016-03-04 2023-04-04 加利福尼亚大学董事会 微生物聚生体及其用途
AU2017252299A1 (en) * 2016-04-20 2018-12-06 Human Longevity, Inc. Use of a microbiome profile to detect liver disease
RU2749436C2 (ru) * 2016-05-11 2021-06-10 Юниверсити Оф Саутерн Калифорния Диета, имитирующая голодание (FMD), в качестве иммунорегуляторного лечения желудочно-кишечных аутоиммунных/воспалительных заболеваний
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
EP3606325B1 (en) 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
CN107271674B (zh) * 2017-06-13 2019-05-07 首都医科大学附属北京地坛医院 一种用于脂肪性肝炎检测的靶标志物gp73及检测应用方法
AU2019253714A1 (en) 2018-04-10 2020-11-26 Siolta Therapeutics, Inc. Microbial consortia
CN108504739A (zh) * 2018-05-15 2018-09-07 浙江大学 一种用于肝癌早期诊断的生物标志物及其应用
EP3899015A1 (en) * 2018-12-19 2021-10-27 Astrazeneca AB Biomarker of pnpla3 expression
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CN114786690A (zh) 2019-10-07 2022-07-22 谢尔塔治疗公司 治疗性药物组合物
CN111884792B (zh) * 2020-06-30 2021-07-09 深圳市永达电子信息股份有限公司 基于忆阻器混沌序列的本征态网络电路信号制备系统和方法
US11688507B2 (en) 2020-12-29 2023-06-27 Kpn Innovations, Llc. Systems and methods for generating a metabolic dysfunction nourishment program
WO2023122531A2 (en) * 2021-12-20 2023-06-29 Regeneron Pharmaceuticals, Inc. Methods of identifying and evaluating liver inflammation and liver fibrosis in a subject by determining a stratified score based on gene expression

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
CA2404260A1 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
CA2476755C (en) * 2001-12-17 2014-08-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US8119365B2 (en) * 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
WO2004092365A1 (ja) * 2003-04-13 2004-10-28 Kyushu Tlo Company Limited 肝障害関連遺伝子群の抽出選択法およびそれを用いた肝障害もしくは肝機能評価・診断方法
US7860656B2 (en) * 2005-02-03 2010-12-28 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of hepatic steatosis using biochemical markers
HUE027400T2 (en) * 2005-02-18 2016-10-28 Glaxosmithkline Biologicals Sa Proteins and nucleic acids from meningitis / sepsis with Escherichia coli
FR2893136A1 (fr) * 2005-11-10 2007-05-11 Sanofi Aventis Sa Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies
US20110165568A1 (en) * 2009-12-31 2011-07-07 Life Technologies Corporation Sequences of e.coli 055:h7 genome
CN102939391A (zh) * 2010-03-01 2013-02-20 国家农艺研究院 炎症性肠病的诊断方法
JP5757032B2 (ja) * 2010-04-05 2015-07-29 学校法人東京医科大学 ｍｉＲＮＡを利用した慢性肝疾患の線維化の検査方法
JP2012125215A (ja) * 2010-12-17 2012-07-05 Osaka City Univ 肝線維症の存在及び／又は肝線維症の重症度の判定方法、判定マーカー、判定用キット、肝線維症の治療の効果予測方法、効果予測マーカー、並びに効果予測用キット
WO2012105590A1 (ja) * 2011-02-01 2012-08-09 アステラス製薬株式会社 非アルコール性脂肪肝炎の鑑別マーカー及び当該マーカーを指標とした非アルコール性脂肪肝炎の診断方法
US20140179726A1 (en) * 2011-05-19 2014-06-26 Virginia Commonwealth University Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
WO2013036290A1 (en) 2011-09-09 2013-03-14 Yale University Compositions and methods for assessing and treating inflammatory diseases and disorders
US20140377278A1 (en) * 2012-01-10 2014-12-25 Yale University Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders
WO2014060537A1 (en) 2012-10-17 2014-04-24 Institut National De La Recherche Agronomique Prognostic of diet impact on obesity-related co-morbidities
DK2909336T3 (da) 2012-10-17 2018-08-20 Agronomique Inst Nat Rech Bestemmelse af reduceret tarmbakteriemangfoldighed
US20150284779A1 (en) 2012-10-17 2015-10-08 Institut National De La Recherche Agronomique Determination of a tendency to gain weight
US9459650B2 (en) 2014-03-17 2016-10-04 Qualcomm Incorporated Clock pulse generator for multi-phase signaling

Also Published As

Publication number Publication date
JP2015535177A (ja) 2015-12-10
EP2909334B1 (en) 2020-06-24
CN104769132A (zh) 2015-07-08
US10626471B2 (en) 2020-04-21
NZ707035A (en) 2018-11-30
IL238025B (en) 2020-05-31
JP2019092522A (ja) 2019-06-20
IL238025A0 (en) 2015-05-31
EP2909334A1 (en) 2015-08-26
JP6752016B2 (ja) 2020-09-09
AU2013333882B2 (en) 2019-05-16
AU2013333882A1 (en) 2015-05-07
CA2886748A1 (en) 2014-04-24
US10036074B2 (en) 2018-07-31
US20160068890A1 (en) 2016-03-10
IN2015DN03796A (da) 2015-10-02
WO2014060555A1 (en) 2014-04-24
CN104769132B (zh) 2018-05-08
ES2821383T3 (es) 2021-04-26
BR112015008621A2 (pt) 2018-08-28
MX2015004844A (es) 2015-11-16
AU2019210666A1 (en) 2019-08-22
US20180251819A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
DK2909334T3 (da) Gensignaturer af inflammatoriske lidelser, som er relateret til leveren og Crohns sygdom
DK3238709T3 (da) Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK2794604T3 (da) Hidtil ukendte dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af inflammatoriske lidelse
DK3252160T3 (da) Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation
DK3421051T3 (da) Fremgangsmåder til glycokonjugering og sammensætninger
DK3444261T3 (da) 2,2-difluorpropionamidderivat af bardoxolonmethyl, farmaceutiske sammensætninger og polymorfer deraf til anvendelse ved behandling af visse lidelser
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK2804587T3 (da) Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed
DK3444342T3 (da) Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
BR112015010947A2 (pt) composições e métodos para aumentar o metabolismo energético.
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
DK3287787T3 (da) Anti-tumorrespons til modificerede selv-epitoper
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
DK2755481T3 (da) Anvendelse af alginatoligomerer til at forøge virkningerne af svampemidler
BR112014016389A2 (pt) composições e métodos para o tratamento de doenças e distúrbios hepáticos
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika
DK2838907T3 (da) Aminosteroider til behandlingen af en ptp1b-associeret sygdom
DK2665793T3 (da) Azeotroplignende sammensætninger af trans-1,1,1,4,4,4-hexafluor-2-buten og vand
DK3175852T3 (da) Difluorlactamsammensætninger til EP4-medierede osteorelaterede sygdomme og tilstande
BR302012006076S1 (pt) "configuração construtiva aplicada à barbatana"
DK2786757T3 (da) 2-substitueret oleanolsyre-derivat, fremgangsmåde til fremstilling af samme, og anvendelse deraf